Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis
Laure Gilles, … , Ayalew Tefferi, John D. Crispino
Laure Gilles, … , Ayalew Tefferi, John D. Crispino
Published February 27, 2017
Citation Information: J Clin Invest. 2017;127(4):1316-1320. https://doi.org/10.1172/JCI82905.
View: Text | PDF
Brief Report Hematology Article has an altmetric score of 6

Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis

  • Text
  • PDF
Abstract

Primary myelofibrosis (PMF) is a clonal hematologic malignancy characterized by BM fibrosis, extramedullary hematopoiesis, circulating CD34+ cells, splenomegaly, and a propensity to evolve to acute myeloid leukemia. Moreover, the spleen and BM of patients harbor atypical, clustered megakaryocytes, which contribute to the disease by secreting profibrotic cytokines. Here, we have revealed that megakaryocytes in PMF show impaired maturation that is associated with reduced GATA1 protein. In investigating the cause of GATA1 downregulation, our gene-expression study revealed the presence of the RPS14-deficient gene signature, which is associated with defective ribosomal protein function and linked to the erythroid lineage in 5q deletion myelodysplastic syndrome. Surprisingly, reduced GATA1 expression and impaired differentiation were limited to megakaryocytes, consistent with a proproliferative effect of a GATA1 deficiency on this lineage. Importantly, expression of GATA1 effectively rescued maturation of PMF megakaryocytes. Together, these results suggest that ribosomal deficiency contributes to impaired megakaryopoiesis in myeloproliferative neoplasms.

Authors

Laure Gilles, Ahmet Dirim Arslan, Christian Marinaccio, Qiang Jeremy Wen, Priyanka Arya, Maureen McNulty, Qiong Yang, Jonathan C. Zhao, Katerina Konstantinoff, Terra Lasho, Animesh Pardanani, Brady Stein, Isabelle Plo, Sriram Sundaravel, Amittha Wickrema, Annarita Migliaccio, Sandeep Gurbuxani, William Vainchenker, Leonidas C. Platanias, Ayalew Tefferi, John D. Crispino

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 Total
Citations: 1 3 5 8 8 8 9 4 1 47
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (47)

Title and authors Publication Year
High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression
Resar LM, Luo LZ
International Journal of Molecular Sciences 2025
Delivery of miR-15b-5p via magnetic nanoparticle-enhanced bone marrow mesenchymal stem cell-derived extracellular vesicles mitigates diabetic osteoporosis by targeting GFAP
Xu C, Wang Z, Liu Y, Duan K, Guan J
Cell Biology and Toxicology 2024
Association between PDCD6-VNTR polymorphism and urinary cancer susceptibility.
Yang GE, Kim MH, Jeong MS, Lee SY, Choi YH, Nam JK, Kim TN, Leem SH
Genes & genomics 2024
Reduced GATA1 levels are associated with ineffective erythropoiesis in sickle cell anemia
El Hoss S, Shangaris P, Brewin J, Psychogyiou ME, Ng C, Pedler L, Rooks H, Gotardo ÉM, Gushiken LF, Brito PL, Nicolaides KH, Conran N, Rees DC, Strouboulis J
Haematologica 2024
Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
Blatti C, de la Fuente J, Gao H, Marín-Goñi I, Chen Z, Zhao SD, Tan W, Weinshilboum R, Kalari KR, Wang L, Hernaez M
Cancer research 2023
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.
Willekens C, Laplane L, Dagher T, Benlabiod C, Papadopoulos N, Lacout C, Rameau P, Catelain C, Alfaro A, Edmond V, Signolle N, Marchand V, Droin N, Hoogenboezem R, Schneider RK, Penson A, Abdel-Wahab O, Giraudier S, Pasquier F, Marty C, Plo I, Villeval JL, Constantinescu SN, Porteu F, Vainchenker W, Solary E
Leukemia 2023
GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis
Gobbo F, Zingariello M, Verachi P, Falchi M, Arciprete F, Martelli F, Peli A, Mazzarini M, Vierstra J, Mead-Harvey C, Dueck AC, Sarli G, Nava S, Sgalla G, Richeldi L, Migliaccio AR
2023
Perspectives of current understanding and therapeutics of Diamond-Blackan anemia.
Liu Y, Karlsson S
Leukemia 2023
Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape
Mahmud M, Vasireddy S, Gowin K, Amaraneni A
International journal of molecular sciences 2023
A Congenital Anemia Reveals Distinct Targeting Mechanisms for Master Transcription Factor GATA1
L Ludwig, C Lareau, E Bao, N Liu, T Utsugisawa, A Tseng, S Myers, J Verboon, J Ulirsch, W Luo, C Muus, C Fiorini, M Olive, C Vockley, M Munschauer, A Hunter, H Ogura, T Yamamoto, H Inada, S Nakagawa, S Ozono, V Subramanian, R Chiarle, B Glader, S Carr, M Aryee, A Kundaje, S Orkin, A Regev, T McCavit, H Kanno, V Sankaran
Blood 2022
SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation
Y Gao, R Wang, J Liu, K Zhao, X Qian, X He, H Liu
International journal of biological sciences 2022
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1low Mice
P Verachi, F Gobbo, F Martelli, A Martinelli, G Sarli, A Dunbar, R Levine, R Hoffman, M Massucci, L Brandolini, C Giorgio, M Allegretti, A Migliaccio
Frontiers in Oncology 2022
Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis
Varricchio L, Hoffman R
Frontiers in Oncology 2022
HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression.
Li L, Kim JH, Lu W, Williams DM, Kim J, Cope L, Rampal RK, Koche RP, Xian L, Luo LZ, Vasiljevic M, Matson DR, Zhao ZJ, Rogers O, Stubbs MC, Reddy K, Romero AR, Psaila B, Spivak JL, Moliterno AR, Resar LMS
Blood 2022
Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis.
Hatzimichael E, Timotheatou D, Koumpis E, Benetatos L, Makis A
2022
Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape.
Tefferi A, Gangat N, Pardanani A, Crispino JD
Cancer research 2022
Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1(low) mouse model.
Verachi P, Gobbo F, Martelli F, Falchi M, di Virgilio A, Sarli G, Wilke C, Bruederle A, Prahallad A, Arciprete F, Zingariello M, Migliaccio AR
Experimental Hematology 2022
The Role of Megakaryocytes in Myelofibrosis
J Melo-Cardenas, AR Migliaccio, JD Crispino
Hematology/Oncology Clinics of North America 2021
The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
JL Spivak, AR Moliterno
Frontiers in Oncology 2021
hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1low Mutation in Mice
F Martelli, P Verachi, M Zingariello, M Mazzarini, AM Vannucchi, A Lonetti, B Bacci, G Sarli, AR Migliaccio
Frontiers in Genetics 2021
Disease modifying agents of myeloproliferative neoplasms: a review
SE Lee
Blood Research 2021
Role of β1 integrin in thrombocytopoiesis
M Mazzarini, P Verachi, F Martelli, AR Migliaccio
2021
A patient with a germline GATA2 mutation and primary myelofibrosis
CV Rütsche, E Haralambieva, V Lysenko, S Balabanov, AP Theocharides
Blood Advances 2021
A Novel Megakaryocyte Subpopulation Poised to Exert the Function of HSC Niche as Possible Driver of Myelofibrosis
AR Migliaccio
Cells 2021
TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling
O Peña, A Lubin, C Hockings, J Rowell, Y Jung, Y Hoade, P Dace, L Valdivia, K Tuschl, C Böiers, M Virgilio, S Richardson, E Payne
Blood Advances 2021
Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis
M Zingariello, V Rosti, AM Vannucchi, P Guglielmelli, M Mazzarini, G Barosi, ML Genova, AR Migliaccio
Frontiers in Oncology 2020
Management of myelofibrosis after ruxolitinib failure
P Bose, S Verstovsek
Leukemia & Lymphoma 2020
Integrated analyses of translatome and proteome identify the rules of translation selectivity in RPS14-deficient cells
I Boussaid, SL Goff, C Floquet, EF Gautier, A Raimbault, PJ Viailly, DA Dulaimi, B Burroni, I Dusanter-Fourt, I Hatin, P Mayeux, B Cosson, M Fontenay
Haematologica 2020
MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment
J Grabek, J Straube, M Bywater, SW Lane
Cells 2020
Sexual dimorphism in aging hematopoiesis: an earlier decline of hematopoietic stem and progenitor cells in male than female mice
EY So, EM Jeong, KQ Wu, PM Dubielecka, AM Reginato, PJ Quesenberry, OD Liang
Aging 2020
Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms
P Bose, L Masarova, S Verstovsek
Cancers 2020
Lysyl oxidase inhibition in primary myelofibrosis: A renewed strategy
Piasecki A, Leiva O, Ravid K
Archives of stem cell and therapy 2020
The mechanisms of pathological extramedullary hematopoiesis in diseases.
Yang X, Chen D, Long H, Zhu B
Cellular and molecular life sciences : CMLS 2020
The Pleiotropic Effects of GATA1 and KLF1 in Physiological Erythropoiesis and in Dyserythropoietic Disorders
G Barbarani, C Fugazza, J Strouboulis, AE Ronchi
Frontiers in physiology 2019
New Concepts of Treatment for Patients with Myelofibrosis
P Bose, M Alfayez, S Verstovsek
Current Treatment Options in Oncology 2019
Impaired human hematopoiesis due to a cryptic intronic GATA1 splicing mutation
NJ Abdulhay, C Fiorini, JM Verboon, LS Ludwig, JC Ulirsch, B Zieger, CA Lareau, X Mi, A Roy, EA Obeng, M Erlacher, N Gupta, SB Gabriel, BL Ebert, CM Niemeyer, RN Khoriaty, P Ancliff, HT Gazda, MW Wlodarski, VG Sankaran
Journal of Experimental Medicine 2019
Aurora Kinase A Inhibition: A Mega-Hit for Myelofibrosis Therapy?
RT Piszczatowski, U Steidl
Clinical cancer research 2019
Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks
S Sundaravel, WL Kuo, JJ Jeong, GS Choudhary, S Gordon-Mitchell, H Liu, TD Bhagat, KL McGraw, S Gurbuxani, AF List, A Verma, A Wickrema
Clinical cancer research 2019
Novel strategies for the treatment of myelofibrosis driven by recent advances in understanding the role of the microenvironment in its etiology
Z Eran, M Zingariello, MT Bochicchio, C Bardelli, AR Migliaccio
F1000Research 2019
Advances in potential treatment options for myeloproliferative neoplasm associated myelofibrosis
P Bose
Expert Opinion on Orphan Drugs 2019
Novel targets to cure primary myelofibrosis from studies on Gata1low mice
M Zingariello, F Martelli, P Verachi, C Bardelli, F Gobbo, M Mazzarini, AR Migliaccio
IUBMB Life 2019
Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice
O Leiva, SK Ng, S Matsuura, V Chitalia, H Lucero, A Findlay, C Turner, W Jarolimek, K Ravid
International Journal of Hematology 2019
Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond
EH Bresnick, KJ Hewitt, C Mehta, S Keles, RF Paulson, KD Johnson
Development (Cambridge, England) 2018
GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy
T Ling, JD Crispino, M Zingariello, F Martelli, AR Migliaccio
Expert Review of Hematology 2018
Management of Myelofibrosis-Related Cytopenias
P Bose, S Verstovsek
Current Hematologic Malignancy Reports 2018
Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis
MK Song, BB Park, JE Uhm
International journal of molecular sciences 2018
The thrombopoietin/MPL axis is activated in the Gata1low mouse model of myelofibrosis and is associated with a defective RPS14 signature
M Zingariello, L Sancillo, F Martelli, F Ciaffoni, M Marra, L Varricchio, RA Rana, C Zhao, JD Crispino, AR Migliaccio
Blood Cancer Journal 2017

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 7 X users
Referenced in 1 Wikipedia pages
66 readers on Mendeley
See more details